Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Mar 7, 2023
- Accession no.
- 0001209191-23-016811
- Filed
- Mar 7, 2023
- Trade date
- Mar 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $14.0K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001209191-23-023787 (Apr 7, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Common Stock | SSaleDisposed | −6,806 | $2.06 | −$14,020.36 | 3,064,560 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.